APPOS - San Francisco


August 20th - August 21st, 2021

Agenda

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Pacific Time Zone

Friday, August 20, 2021

7:00am Registration Open & Breakfast Available in Exhibit Hall

8:00am

Horizon CME App Overview

8:10am Welcome, Introductions, & CE Housekeeping

8:15am

(01) Improving Outcomes in BRAF-Mutant mCRC Through Screening and Targeted Therapy
This session is supported by an independent educational grant from Pfizer.

9:15am Break - Refreshments in Exhibit Hall
9:35am

(02) HR+/HER2- Metastatic Breast Cancer: An Update for APPs
» Jessica Foran, NP - Stanford

10:35am

Break - Refreshments in Exhibit Hall

10:55am   

(03) Dermatological Side Effects in Oncology: A Focus on Immunotherapy and Targeted Therapy 
» Bernice Kwong, MD - Stanford

11:55am Non-CME/CE Symposium Presentation Sponsored by Taiho Oncology

12:45pm

Dessert Break in Exhibit Hall

1:05pm

(04) Nutrition in Patients with Cancer
» Alison Ryan, RD, PA-C - Diablo Valley Oncology

2:05pm

Break - Refreshments in Exhibit Hall

2:25pm

BCOP(05) Cancer-Related Thrombosis: The Great Debate on the Best Way to Anticoagulate

3:40pm Networking Reception
4:00pm Dinner Invitation Sponsored by AstraZeneca DDR Division

Saturday, August 21, 2021

7:00am Check-in & Breakfast Available in Exhibit Hall

8:00am

Horizon CME App Overview

8:10am Welcome, Introductions, & CE Housekeeping

8:15am

(06) Cannabis in Cancer Care
» Donald Abrams, MD - UCSF

9:15am Break - Refreshments in Exhibit Hall
9:35am

(07) The Evolution of Drug Therapy in Oncology: Recent Advances in Cancer Drug Therapy
» Julie Guglielmo, PharmD - UC Davis

10:35am

Break - Refreshments in Exhibit Hall

10:55am   

(08) Chimeric Antigen Receptor (CAR) T-cell Therapy - A Case-Based Update
» Mimi Lo, PharmD - UCSF

11:55am

Lunch & Non-CME/CE Presentation Sponsored by Incyte Corporation (Jakafi)
Clinical Cases in Polycythemia Vera: When to Intervene With Jakafi® (ruxolitinib) | Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
» Rhonda Hewitt, NP - Stanford Cancer Center

12:45pm

Dessert Break in Exhibit Hall

1:05pm

(09) Acute Myeloid Leukemia: Customizing Therapy Based Upon Patient- and Disease-Specific Characteristics
» Tian Zhang, MD, PhD - Stanford University

2:05pm

Break - Refreshments in Exhibit Hall

2:25pm

(10) Managing Patients with Relapsed/Refractory Multiple Myeloma: An Update on Emerging Strategies
» Nancy Wong, NP - UCSF

3:25pm Closing Comments
Register
Course starts in 18 days

Base Price $75.00 Advanced Deadline: 8/5/2021